[{"address1": "800 Chesapeake Drive", "city": "Redwood City", "state": "CA", "zip": "94063", "country": "United States", "phone": "617 984 6300", "website": "https://www.maplightrx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders. The company's products include ML-007C-MA, a fixed-dose combination of an M 1 /M 4 muscarinic agonist for the treatment of schizophrenia and Alzheimer's disease psychosis; ML-004 for the treatment of social communication deficit and/or irritability in autism spectrum disorder; ML-021 for the treatment of motor deficits in Parkinson's disease; and ML-009, a G-protein-coupled receptor 52 positive allosteric modulator for the treatment of hyperactivity, impulsivity and agitation-related disorders. The company also develops platform identifying neural circuits causally linked to disease and targeting those circuits for therapeutic modulation. MapLight Therapeutics, Inc. was formerly known as Alvarado Therapeutics, Inc. and changed its name to MapLight Therapeutics, Inc. in August 2019. MapLight Therapeutics, Inc. was incorporated in 2018 and is based in Redwood City, California.", "fullTimeEmployees": 114, "companyOfficers": [{"maxAge": 1, "name": "Dr. Christopher A. Kroeger M.B.A., M.D., Ph.D.", "age": 56, "title": "Founder, President, CEO & Director", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 910762, "exercisedValue": 0, "unexercisedValue": 2925972}, {"maxAge": 1, "name": "Dr. Robert C. Malenka M.D., Ph.D.", "age": 69, "title": "Co-Founder, Director & Member of Scientific Advisory Board", "yearBorn": 1955, "fiscalYear": 2024, "totalPay": 140000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Vishwas  Setia", "age": 37, "title": "Chief Financial Officer", "yearBorn": 1987, "fiscalYear": 2024, "totalPay": 508078, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Erin Pennock Foff M.D., Ph.D.", "age": 47, "title": "Chief Medical Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 687260, "exercisedValue": 0, "unexercisedValue": 1131486}, {"maxAge": 1, "name": "Dr. Karoly  Nikolich Ph.D.", "age": 76, "title": "Founder", "yearBorn": 1948, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Karl  Deisseroth M.D., Ph.D.", "title": "Co-Founder & Member of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jonathan  Gillis CPA", "age": 43, "title": "Chief Administrative & Accounting Officer", "yearBorn": 1981, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. James Woodruff Lillie Ph.D.", "age": 68, "title": "Chief Scientific Officer", "yearBorn": 1956, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kristopher L. Hanson J.D.", "age": 52, "title": "General Counsel & Secretary", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Anatol  Kreitzer Ph.D.", "age": 50, "title": "Chief Discovery Officer", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 20.095, "open": 20.24, "dayLow": 20.04, "dayHigh": 21.38, "regularMarketPreviousClose": 20.095, "regularMarketOpen": 20.24, "regularMarketDayLow": 20.04, "regularMarketDayHigh": 21.38, "payoutRatio": 0.0, "volume": 179596, "regularMarketVolume": 179596, "averageVolume": 380084, "averageVolume10days": 334490, "averageDailyVolume10Day": 334490, "bid": 19.81, "ask": 21.5, "bidSize": 3, "askSize": 3, "marketCap": 939221824, "fiftyTwoWeekLow": 12.24, "fiftyTwoWeekHigh": 21.395, "allTimeHigh": 21.395, "allTimeLow": 12.24, "fiftyDayAverage": 15.818939, "twoHundredDayAverage": 15.818939, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 12890766336, "profitMargins": 0.0, "floatShares": 231643924, "sharesOutstanding": 45373033, "sharesShort": 763833, "sharesShortPriorMonth": 198860, "sharesShortPreviousMonthDate": 1761868800, "dateShortInterest": 1764288000, "sharesPercentSharesOut": 0.0168, "heldPercentInsiders": 0.50759, "heldPercentInstitutions": 0.081709996, "shortRatio": 2.91, "shortPercentOfFloat": 0.0171, "impliedSharesOutstanding": 45373033, "bookValue": -0.45, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -102833000, "trailingEps": -2.48, "enterpriseToEbitda": -119.524, "52WeekChange": 0.095692515, "SandP52WeekChange": 0.13613915, "quoteType": "EQUITY", "currentPrice": 20.7, "targetHighPrice": 34.0, "targetLowPrice": 28.0, "targetMeanPrice": 31.0, "targetMedianPrice": 31.0, "recommendationMean": 1.25, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 227168000, "totalCashPerShare": 0.373, "ebitda": -107851000, "totalDebt": 6006000, "quickRatio": 12.238, "currentRatio": 13.215, "debtToEquity": 2.572, "operatingCashflow": -112796000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "MPLT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1761571800000, "corporateActions": [], "postMarketTime": 1765574409, "regularMarketTime": 1765573202, "exchange": "NMS", "messageBoardId": "finmb_605975835", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "MapLight Therapeutics, Inc.", "longName": "MapLight Therapeutics, Inc.", "postMarketChangePercent": -3.3816462, "postMarketPrice": 20.0, "postMarketChange": -0.70000076, "regularMarketChange": 0.605001, "regularMarketDayRange": "20.04 - 21.38", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 380084, "fiftyTwoWeekLowChange": 8.460001, "fiftyTwoWeekLowChangePercent": 0.6911766, "fiftyTwoWeekRange": "12.24 - 21.395", "fiftyTwoWeekHighChange": -0.6949997, "fiftyTwoWeekHighChangePercent": -0.03248421, "fiftyTwoWeekChangePercent": 9.569252, "earningsTimestamp": 1764855000, "earningsTimestampStart": 1764855000, "earningsTimestampEnd": 1764855000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.48, "fiftyDayAverageChange": 4.8810616, "fiftyDayAverageChangePercent": 0.30855808, "twoHundredDayAverageChange": 4.8810616, "twoHundredDayAverageChangePercent": 0.30855808, "priceToBook": -46.000004, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2025-10-27", "averageAnalystRating": "1.3 - Strong Buy", "regularMarketChangePercent": 3.01071, "regularMarketPrice": 20.7, "marketState": "CLOSED", "displayName": "MapLight Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-12-13"}]